GlassScriptPhysician profile
Sunil K Goli
NPI 1124045083
$5,758.32
in general payments reported to CMS, 2019-2025
38 companies · $589 in 2025
The $589 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $638 · 2020: $562 · 2021: $859 · 2022: $1,409 · 2023: $1,024 · 2024: $676 · 2025: $589.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,254 · Education: $35.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,253.78 |
| Education | $35.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $472.11 | 2020-2025 | |
| Argenx US, INC. | $459.05 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Pfizer INC. | $402.17 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $389.24 | 2019-2024 | Austedo Xr, Ajovy |
| Lilly USA, LLC | $368.85 | 2019-2025 | Emgality, Reyvow, Zepbound |
| Harmony Biosciences LLC | $335.78 | 2020-2025 | Wakix |
| Neurocrine Biosciences, INC. | $314.75 | 2022-2023 | Ingrezza, Ongentys |
| Supernus Pharmaceuticals, INC. | $282.95 | 2019-2023 | |
| Jazz Pharmaceuticals INC. | $276.71 | 2019-2025 | |
| Abbvie INC. | $275.71 | 2021-2025 | |
| Ucb, INC. | $225.15 | 2019-2021 | |
| Mdd US Operations, LLC | $200.24 | 2023-2024 | Gocovri, Gocovri |
| Lundbeck LLC | $198.94 | 2022-2024 | Vyepti |
| Amgen INC. | $166.20 | 2019-2023 | Aimovig |
| Sk Life Science, INC. | $151.19 | 2020-2022 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Goli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.